NL2035805A - Method for preparing enzyme distillate and application thereof as eye care solution - Google Patents
Method for preparing enzyme distillate and application thereof as eye care solution Download PDFInfo
- Publication number
- NL2035805A NL2035805A NL2035805A NL2035805A NL2035805A NL 2035805 A NL2035805 A NL 2035805A NL 2035805 A NL2035805 A NL 2035805A NL 2035805 A NL2035805 A NL 2035805A NL 2035805 A NL2035805 A NL 2035805A
- Authority
- NL
- Netherlands
- Prior art keywords
- fermentation
- distillate
- eye care
- enzyme
- care solution
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 30
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 21
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 7
- 239000011707 mineral Substances 0.000 claims abstract description 7
- 238000010565 inoculated fermentation Methods 0.000 claims abstract description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 4
- 230000032683 aging Effects 0.000 claims abstract description 4
- 238000004821 distillation Methods 0.000 claims abstract description 4
- 241000589212 Acetobacter pasteurianus Species 0.000 claims description 9
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 9
- 244000286779 Hansenula anomala Species 0.000 claims description 9
- 235000014683 Hansenula anomala Nutrition 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 8
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 8
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 239000008121 dextrose Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 244000201986 Cassia tora Species 0.000 claims description 5
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 244000119298 Emblica officinalis Species 0.000 claims description 5
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 5
- 244000167230 Lonicera japonica Species 0.000 claims description 5
- 235000017617 Lonicera japonica Nutrition 0.000 claims description 5
- 241000037831 Polygonatum sibiricum Species 0.000 claims description 5
- 244000251905 Pseudocydonia sinensis Species 0.000 claims description 5
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 claims description 5
- 235000011449 Rosa Nutrition 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 244000077233 Vaccinium uliginosum Species 0.000 claims description 5
- 235000011720 Vaccinium uliginosum Nutrition 0.000 claims description 5
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 claims description 3
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 229910001414 potassium ion Inorganic materials 0.000 claims description 3
- 229910001415 sodium ion Inorganic materials 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims 6
- 238000010564 aerobic fermentation Methods 0.000 claims 3
- 239000001963 growth medium Substances 0.000 claims 2
- 238000009630 liquid culture Methods 0.000 claims 2
- 239000012869 germination medium Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 10
- 208000003464 asthenopia Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 4
- 210000001525 retina Anatomy 0.000 abstract description 4
- 238000012258 culturing Methods 0.000 abstract description 3
- 230000004377 improving vision Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 16
- 230000003385 bacteriostatic effect Effects 0.000 description 14
- 241000222122 Candida albicans Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 229940095731 candida albicans Drugs 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- SFAYBQDGCKZKMH-UHFFFAOYSA-N BNCC Chemical compound BNCC SFAYBQDGCKZKMH-UHFFFAOYSA-N 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000486634 Bena Species 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/02—Acetobacter
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (8)
1. Werkwijze voor het bereiden van enzymdestillaat, die de volgende stappen omvat: (1) stamkweek I, stammen: wickerhamomyces anomalus CICC 1312, acetobacter pasteurianus CICC 20002, lactobacillus acidophilus CICC6096 en bifidobacterium adolescentis CICC6180, en II, kiemmedium: moutextractmedium, dextrose-agarmedium, MRS- vloeibarekweekmedium; het aeroob fermenteren van wickerhamomyces anomalus CICC 1312 met het moutextractmedium bij 28 °C gedurende 36 uur, het aeroob fermenteren van acetobacterpasteurianus CICC 20002 met het dextrose-agarmedium bij 30 °C gedurende 24 uur en het anaeroob fermenteren van /actobacillus acidophilus en bifidobacterium adolescentis met het MRS-vloeibarekweekmedium bij 37 °C gedurende 24 uur; (2) geïnoculeerde fermentatie; het inenten van de gekweekte stammen in een fermentatiemedium volgens een verhouding (0,5% wickerhamomyces anomalus, 1% acetobacterpasteurianus, 1,5% lactobacillus acidophilus en bifidobacterium adolescentis), waarbij fermentatieomstandigheden zijn: aerobe fermentatie bij 35°C gedurende 3 dagen, gevolgd door anaerobe fermentatie bij 30°C gedurende 3 dagen; en (3) veroudering het overbrengen, na fermentatie, naar een opslagtank voor anaerobe fermentatie bij een normale temperatuur gedurende 180 dagen, en het destilleren met destillatie-apparatuur om het enzymdestillaat te bereiden.
2. Werkwijze voor het bereiden van enzymdestillaat volgens conclusie 1, waarbij elke component van het fermentatiemedium in stap (2) een geneeskrachtige en eetbare homologe grondstof is, en elke component en de inhoud daarvan het volgende omvat: lonicera japonica 1-3,5 g/L, dendranthema morifolium 1-3 g/L, polygonatum sibiricum 0,5-2,5 g/L, rosa roxbunghii 3-5 g/L, daucus carota 1-4 g/L, phyllanthus emblica 1-4 g/L, chaenomeles sinensis 2-4 g/L, vaccinium uliginosum 2-5 g/L, catia tora linn 0,5-2 g/L en sucrose 15-25 g/L.
3. Oogzorgoplossing waarbij componenten van de oogzorgoplossing en massapercentages daarvan het volgende omvatten: enzymdestillaat 80%, normale zoutoplossing 15% en mineraalenergiewater 5%.
4. Oogzorgoplossing volgens conclusie 3, waarbij het mineraalenergiewater kaliumionen, magnesiumionen, calciumionen, natriumionen en metasilicisch zuur omvat.
5. Werkwijze voor het bereiden van de oogzorgoplossing volgens conclusie 3, die de volgende stappen omvat:
a. het doseren;
b. het roeren;
c. ultrasone verstoring;
d. microporeuze membraanfiltratie; en e. sterilisatie.
6. Werkwijze voor het bereiden van de oogzorgoplossing volgens conclusie 5, waarbij in stap d het membraan een specificatie van 0,22 um heeft.
7. Werkwijze voor het bereiden van de oogzorgoplossing volgens conclusie 5, waarbij in stap e de sterilisatie een temperatuur van 105°C heeft, en de sterilisatie een duur van 15 minuten heeft.
8. Werkwijze voor het bereiden van de oogzorgoplossing volgens conclusie 5, waarbij in stap c de ultrasone verstoring een frequentie heeft van 15-20 KhZ, en de ultrasone verstoring een duur van 3-6 minuten heeft.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211143205.6A CN115475116A (zh) | 2022-09-20 | 2022-09-20 | 一种酵素蒸馏液的制备方法及其作为眼部护理液的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2035805A true NL2035805A (en) | 2024-03-26 |
Family
ID=84424142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2035805A NL2035805A (en) | 2022-09-20 | 2023-09-15 | Method for preparing enzyme distillate and application thereof as eye care solution |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115475116A (nl) |
NL (1) | NL2035805A (nl) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102600061A (zh) * | 2012-03-06 | 2012-07-25 | 吉林敖东大高酵素有限公司 | 一种植物酵素皮肤护理液的制法 |
CN106173613B (zh) * | 2014-10-08 | 2019-10-25 | 中国科学院上海生命科学研究院 | 一种利用益生菌发酵制备果蔬或谷物或药食同源酵素保健食品的方法 |
CN104543844A (zh) * | 2015-01-26 | 2015-04-29 | 杨志刚 | 一种蓝莓酵素 |
CN105124577B (zh) * | 2015-09-01 | 2018-01-02 | 福建天斯顿生物科技有限公司 | 一种果蔬酵素的制备方法 |
CN105105134A (zh) * | 2015-09-24 | 2015-12-02 | 上海韬鸿化工科技有限公司 | 蓝莓酵素及其制备方法 |
CN109875039A (zh) * | 2019-03-20 | 2019-06-14 | 广东利泰大健康产业股份有限公司 | 一种混菌分段发酵余甘子酵素产品的制备工艺及制备的酵素产品 |
CN110237160A (zh) * | 2019-07-17 | 2019-09-17 | 广西天缘绿生物科技有限公司 | 眼部冷敷凝露 |
CN113197987A (zh) * | 2021-05-07 | 2021-08-03 | 山东凯漫生物科技有限公司 | 一种眼睛护理液的制备方法及应用 |
CN114246814A (zh) * | 2022-01-25 | 2022-03-29 | 湖北恩景生物科技有限公司 | 酵素眼部护理液 |
-
2022
- 2022-09-20 CN CN202211143205.6A patent/CN115475116A/zh active Pending
-
2023
- 2023-09-15 NL NL2035805A patent/NL2035805A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN115475116A (zh) | 2022-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101328469B (zh) | 具有酒精性肝损伤保护功能的嗜热链球菌grx02及其用途 | |
CN113143812B (zh) | 一种卡瓦胡椒发酵物的制备方法和产品及其在化妆品中的应用 | |
CN110964673B (zh) | 一种具有高抗氧化性及美白效果的戊糖片球菌及其应用 | |
Jin et al. | Oplopanax elatus adventitious root production through fed-batch culture and their anti-bacterial effects | |
CN114634899A (zh) | 发酵乳杆菌及其应用 | |
CN115927096A (zh) | 一种具有降尿酸功效的药食同源酵素及其制备方法 | |
CN110721136A (zh) | 一种含有康普茶的化妆品原料的制备方法及其应用 | |
CN111904909B (zh) | 一种含有玫瑰发酵液的去屑头皮精华及其制备方法 | |
JP4630389B1 (ja) | 新規酵母及びその酵母で発酵処理した食品の製造法 | |
CN116376731B (zh) | 一种异常威克汉姆酵母菌在制备青刺果提取物中的应用 | |
NL2035805A (en) | Method for preparing enzyme distillate and application thereof as eye care solution | |
CN105543141B (zh) | 一种降胆固醇菌制剂及其制备方法和用途 | |
CN115927128B (zh) | 一种透明颤菌发酵产物及其制备方法与应用 | |
CN114574408B (zh) | 益生菌seuneu-107及应用 | |
CN107410479B (zh) | 一种发酵乳及其制备方法 | |
Kalaba et al. | Antibacterial activity of essential oil of Juniperus communis L. | |
CN105263471A (zh) | 保湿剂 | |
CN112741113B (zh) | 一种防治马铃薯早疫病的微生物制剂及其应用 | |
KR20160076171A (ko) | 복분자로부터 분리한 락토바실러스 플란타룸 균주 및 이를 포함하는 식품 조성물 | |
CN115645330B (zh) | 一种天竺葵提取物及其制备方法与应用 | |
KR20190063534A (ko) | 새로운 바실러스 발효균과 발효홍삼의 배양추출물을 유효성분으로 포함하는 건강기능식품 또는 화장품 조성물 | |
Utama et al. | Antibacterial Activity Test of Indigenous Yeast from Sapodilla Fruit against Staphylococcus aureus and Escherichia coli | |
Prasad et al. | Fate of acidity and alcohol during fermentation of Salalah and Sri Lanka coconut water | |
CN115404189B (zh) | 棒状乳杆菌及其应用 | |
CN107224408B (zh) | 一种植物源广谱抗菌剂及其制备方法和应用 |